# CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting.
*Name:* CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment.
*Times and Dates:* 8 a.m.-5 p.m., November 18, 2004. 8 a.m.-12 p.m., November 19, 2004.
*Place:* Doubletree Hotel—Rockville, 1740 Rockville Pike, Rockville, Maryland.
*Status:* Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.
*Purpose:* This Committee is charged with advising the Secretary, the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs, the support of health care services to persons living with HIV/AIDS, and education of health professionals and the public about HIV/AIDS and other STDs.
*Matters To Be Discussed:* Agenda items include issues pertaining to (1) AIDS Drug Assistance Program (ADAP); (2) Ryan White Reauthorization; and (3) Impact of Crystal Methamphetamine on STD rates and HIV. Agenda items are subject to change as priorities dictate.
**FOR FURTHER INFORMATION CONTACT:**
Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone 404/639-8008, fax 404/639-3125, e-mail *[email protected].*
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: September 30, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).